Hugh Taylor, MD, outlines a stepwise approach to endometriosis therapy, from first-line oral contraceptives to oral GnRH antagonists for progestin-resistant patients.
|Articles|November 30, 2018
Video: Laparoscopic excision of multifocal bowel endometriosis
Nisse V. Clark, MD, Renita Kim, MD, MPH, and Jon Einarsson, MD, PhD, MPH show how they treat multifocal bowel endometriosis in a 25-year-old G0 with dysmenorrhea, dyschezia, and cyclic rectal bleeding.
Advertisement
Nisse V. Clark, MD, Renita Kim, MD, MPH, and Jon Einarsson, MD, PhD, MPH show how they treat multifocal bowel endometriosis in a 25-year-old G0 with dysmenorrhea, dyschezia, and cyclic rectal bleeding.
Advertisement
Related to this article
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Menopause proteomic scores associated with cognitive aging, dementia risk
3
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
4
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
5